DOD-R Stock Overview
Operates as a manufacturer of dietary supplements, cosmetics, and skin care products in Thailand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
DOD Biotech Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿1.71 |
| 52 Week High | ฿3.92 |
| 52 Week Low | ฿1.30 |
| Beta | 1.4 |
| 1 Month Change | -21.56% |
| 3 Month Change | -44.84% |
| 1 Year Change | -53.78% |
| 3 Year Change | -85.00% |
| 5 Year Change | -76.58% |
| Change since IPO | -88.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| DOD-R | TH Personal Products | TH Market | |
|---|---|---|---|
| 7D | -14.5% | -2.8% | -2.3% |
| 1Y | -53.8% | -18.1% | -2.1% |
Return vs Industry: DOD-R underperformed the TH Personal Products industry which returned -18.4% over the past year.
Return vs Market: DOD-R underperformed the TH Market which returned -3.4% over the past year.
Price Volatility
| DOD-R volatility | |
|---|---|
| DOD-R Average Weekly Movement | 5.1% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in TH Market | 8.9% |
| 10% least volatile stocks in TH Market | 2.1% |
Stable Share Price: DOD-R has not had significant price volatility in the past 3 months compared to the TH market.
Volatility Over Time: DOD-R's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Torlarp Chaiyachow | www.dodbiotech.com |
DOD Biotech Public Company Limited operates as a manufacturer of dietary supplements, cosmetics, and skin care products in Thailand. The company offers skincare products, which includes skin clarifying, anti-aging, moisturing, acne control, and dark spot reduction products; and body shaping products, such as metabolic boosting, carbohydrate absorption inhibitors and carb blockers, fat metabolism inhibitors, and DAppetite suppressants. It also provides products for health care, such as brain function, bone and joints, excretory system, sleep aid, immunity boost, vitamins, and blood sugar regulators, as well as visual, hair, and cardiovascular care products; proteins for strengths and muscle function including whey/plant based proteins, power gels, and energy drinks; and body wellness products for men and ladies.
DOD Biotech Public Company Limited Fundamentals Summary
| DOD-R fundamental statistics | |
|---|---|
| Market cap | ฿770.21m |
| Earnings (TTM) | ฿19.71m |
| Revenue (TTM) | ฿708.65m |
39.1x
P/E Ratio1.1x
P/S RatioIs DOD-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOD-R income statement (TTM) | |
|---|---|
| Revenue | ฿708.65m |
| Cost of Revenue | ฿451.34m |
| Gross Profit | ฿257.31m |
| Other Expenses | ฿237.59m |
| Earnings | ฿19.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.044 |
| Gross Margin | 36.31% |
| Net Profit Margin | 2.78% |
| Debt/Equity Ratio | 7.1% |
How did DOD-R perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 17:03 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DOD Biotech Public Company Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wilasinee Boonmasungsong | Globlex Securities Co. Ltd. |
| Hathaichanoke Moonwong | Phillip Securities (Thailand) PCL |
| Apichat Poobunjirdkul | Tisco Securities Co. Ltd. |